EN DE

Kirin Holdings (KNBWF) Fair Value & Analysis

Consumer Defensive · US · Market cap $14.8B

KH Kirin Holdings logo Kirin Holdings KNBWF · US
Price$18.56
Fair Value$16.71
Upside-10.0%
Quality57/100
Watch Kirin Holdings for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 6.1% net margin
Moderate debt · generates free cash flow
2.68% dividend yield
Mixed vs. peers (6/12)
Moderate moat 45/100
Evidence: Medium Range $9.47 – $24.69 Share as image

Fair value as of: Jul 17, 2026

From 23 valuation models · updated 24 days ago

A solid business, currently priced close to our fair value.

What matters now

  • The model range is unusually wide ($9.47 to $24.69). The outcome hinges heavily on assumptions, so read the point estimate with caution.
  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$21.30 $9.37 Fair Value $16.71 Jul 2015 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 17, 2026.

How to read this chart

60‑month range $9.37 – $21.30 · fair‑value band $9.47 – $24.69 · the $18.56 price screens above the $16.71 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 17, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Kirin Holdings (KNBWF) currently trades at $18.56, while our model-based Fair Value estimate is $16.71, implying the stock looks roughly 10.0% fairly valued today. The Quality Score stands at 57/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Kirin Holdings generated revenue of $2.5T at a net margin of 6.1%. Revenue grew 5.0% year over year. It earns a return on equity of 12.2%. Net debt stands at $799B. Fundamentals as of Jul 17, 2026

Our scenario range runs from $9.47 (bear case) to $24.69 (bull case); at $18.56, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 44% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -8% fair-value upside, at -10%, KNBWF screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF $4.78 $8.79 $14.20 80
Rev-Margin DCF $9.07 $17.83 $26.90 74
ROIC Compounder $9.22 $12.06 $15.48 72
All 23 models by family
DCF Models
FCF DCF $4.43 $8.68 $14.61 38
Owner Earnings $0.4508 $3.07 $6.72 31
5Y Revenue Exit $9.07 $17.76 $28.42 39
5Y EBITDA Exit $13.60 $25.68 $39.06 41
5Y P/E Exit $8.48 $16.71 $24.79 38
10Y Revenue Exit $6.69 $14.08 $23.13 36
10Y EBITDA Exit $10.04 $19.39 $30.77 37
10Y P/E Exit $6.85 $13.38 $20.52 35
Earnings-Based
Graham-Dodd $8.31 $17.47 $22.12 54
PEG = 1.0 $2.62 $3.74 $4.86 46
EPV $9.22 $11.74 $13.95 59
Multiples
P/E Multiple $19.25 $25.66 $32.08 63
P/S Multiple $15.58 $20.77 $25.97 58
P/B Multiple $15.58 $20.77 $25.97 55
EV/EBIT $20.65 $29.52 $38.38 53
EV/EBITDA $22.62 $32.14 $41.66 54
EV/Revenue $13.04 $21.18 $29.31 43
Asset-Based
NCAV (Graham) $5.33 $7.14 $10.66 50
Growth DCF
Growth DCF $4.78 $8.79 $14.20 80
Rev-Margin DCF $9.07 $17.83 $26.90 74
Economic Profit
Residual Income $9.74 $11.32 $21.38 61
ROIC Compounder $9.22 $12.06 $15.48 72
Growth Earnings
Growth-Adj P/E $14.13 $20.18 $26.24 68

Widest divergence: Multiples ($21.18) versus Asset-Based ($7.14). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) $2.5T
Revenue growth (YoY) +5.0%
Net margin 6.1%
Return on equity 12.2%
Free cash flow $120B FY2025
P/E ratio 16.3
More key figures
Operating margin 8.4%
EPS (TTM) $1.14
Dividend yield 2.7%
EPS growth (YoY) +11.4%
Net debt $799B FY2025

Figures from reported company fundamentals · as of Jul 17, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 57/100

Of which business quality 55 · Market factors (momentum, volatility) 81

Profitability 46
Margins and returns on capital today
Quality Growth 62
Are margins and returns improving?
Cashflow 48
Earnings quality: real cash, not paper profit
Fin. Strength 48
Balance sheet, leverage, solvency risk
Investment 56
Disciplined investing over empire-building
Low Volatility 89
Calm price path (market factor)
Momentum 71
Price trend over the last 3–12 months (market factor)
52W Momentum 87
Distance to the 52-week high (market factor)
Net Issuance 84
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Kirin Holdings Company, Limited engages in food and beverages, alcoholic beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, soft drinks, dairy products, margarine, jams, and honey. It engages in the management and operation of a chain of Kirin City beer pubs.

Full company description

Kirin Holdings Company, Limited engages in food and beverages, alcoholic beverages, pharmaceuticals, and health science businesses. The company's products include beer, wine, soft drinks, dairy products, margarine, jams, and honey. It engages in the management and operation of a chain of Kirin City beer pubs. The company also produces and sells pharmaceutical products. In addition, it manufactures and sells amino acids and nucleic acids for pharmaceutical and industrial use, as well as bulk pharmaceuticals, machines, cosmetics, and health foods. Further, the company provides logistics, accounting, human resources, and real estate services. Additionally, it is involved in the development of internal information systems and the manufacturing and sale of nutritional supplements. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Nakano, Japan.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Kirin Holdings reported revenue of $2.4T in FY2025 versus $1.8T in FY2021, a compound +7.5%/yr. Reported net income was $148B in FY2025, compounding +25.4%/yr from FY2021.

Growth Quality 70/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
$2.4T
Latest YoY
+4.2%
Avg. growth/yr (3Y)
+7.0%
Avg. growth/yr (5Y)
+5.7%
Avg. growth/yr (35Y)
+3.4%
Revenue +7.5%/yr
FY21 $1.8T
FY22 $2.0T
FY23 $2.1T
FY24 $2.3T
FY25 $2.4T
Net income +25.4%/yr
FY21 $59.8B
FY22 $111B
FY23 $113B
FY24 $58.2B
FY25 $148B

Watch KNBWF: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Kirin Holdings Fair Value". https://www.fairvalue-calculator.com/stock/KNBWF

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Beverages - Brewers · 52 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 57 · Below median
Fair Value upside −10% · Below median
Return on equity (TTM) 12% · Above median
Return on assets 5% · Above median
Net margin (TTM) 6% · Below median
Operating margin (TTM) 8% · Below median
Revenue growth 5% · Above median
Dividend yield (TTM) 2.7% · Below median
Debt / equity 0.65× · Higher than 75% of peers

Valuation Multiples vs Beverages - Brewers median · lower = cheaper

P/E (TTM) 16.3× · Cheaper than median
P/FCF 0.1× · Cheaper than 75% of peers
PEG 1.99× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 20 · sector 34
FUTURE 25 · sector 3
PAST 49 · sector 36
HEALTH 67 · sector 97
DIVIDEND 54 · sector 54

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Alcohol

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Beverages - Brewers stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Anheuser-Busch InBev SA 1ABI €73.62 €41.60 -43%
Ambev S.A ABEV 14,120 ARS 6,060 ARS -57%
Fomento Económico Mexicano, S.A. FEMSAUBD 222.91 MXN 201.74 MXN -9%
Heineken N.V HEIA €77.24 €65.06 -16%
Constellation Brands, Inc STZ $135.72 $177.43 +31%
Carlsberg A/S CARLA kr 1,125 kr 607.30 -46%
Heineken Holding HEIO €71.20 €72.67 +2%
Tsingtao Brewery Company 600600 ¥53.60 ¥63.65 +19%
Budweiser Brewing Company 1876 HK$6.58 HK$6.05 -8%
Molson Coors Canada Inc TPXA C$63.10 C$74.42 +18%

Compare Kirin Holdings with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Kirin Holdings (KNBWF) overvalued or undervalued?
As of Jul 17, 2026, our model estimates a fair value of $16.71 versus a price of $18.56, about −10% (fairly valued).
What is the fair value of KNBWF?
Our model-based fair value for Kirin Holdings is $16.71 (as of Jul 17, 2026), built from audited fundamentals. The current price is $18.56.
What is the quality score of KNBWF?
Kirin Holdings has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Kirin Holdings (KNBWF)?
Kirin Holdings reported trailing-twelve-month revenue of about $2.5T (latest available figure, as of Jul 17, 2026).
What is the net profit margin of KNBWF?
The net profit margin of Kirin Holdings is about 6.1%, meaning it keeps roughly 6.1% of revenue as net income. Based on the latest reported figures.
Does Kirin Holdings pay a dividend?
Kirin Holdings currently shows a dividend yield of about 2.68% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Kirin Holdings and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.